Stock Track | CareDx Plunges 8.58% in Post-Market as Acquisition of Naveris Overshadows Strong Q1 Results

Stock Track04-29

CareDx's stock experienced a significant decline of 8.58% in post-market trading on Wednesday, as investor sentiment turned negative following major corporate announcements.

Despite reporting robust first-quarter 2026 financial results that included a 39% year-over-year revenue increase to $118 million and adjusted earnings per share of $0.34, both beating analyst estimates, the market focused on the company's concurrent announcement of its agreement to acquire Naveris. The precision oncology diagnostics company will be purchased for $160 million in upfront cash with potential milestone payments of up to $100 million.

Market participants appear to be weighing the substantial costs and integration risks associated with the acquisition against the strong quarterly fundamentals, leading to the sharp sell-off in the extended session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1151658029?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-29 12:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151658029","market":"hk","top_or_hot":-1,"title":"Stock Track | CareDx Plunges 8.58% in Post-Market as Acquisition of Naveris Overshadows Strong Q1 Results","media":"Stock Track","content":"<p>CareDx's stock experienced a significant decline of 8.58% in post-market trading on Wednesday, as investor sentiment turned negative following major corporate announcements.</p><p>Despite reporting robust first-quarter 2026 financial results that included a 39% year-over-year revenue increase to $118 million and adjusted earnings per share of $0.34, both beating analyst estimates, the market focused on the company's concurrent announcement of its agreement to acquire Naveris. The precision oncology diagnostics company will be purchased for $160 million in upfront cash with potential milestone payments of up to $100 million.</p><p>Market participants appear to be weighing the substantial costs and integration risks associated with the acquisition against the strong quarterly fundamentals, leading to the sharp sell-off in the extended session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | CareDx Plunges 8.58% in Post-Market as Acquisition of Naveris Overshadows Strong Q1 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | CareDx Plunges 8.58% in Post-Market as Acquisition of Naveris Overshadows Strong Q1 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-29 12:51</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CareDx's stock experienced a significant decline of 8.58% in post-market trading on Wednesday, as investor sentiment turned negative following major corporate announcements.</p><p>Despite reporting robust first-quarter 2026 financial results that included a 39% year-over-year revenue increase to $118 million and adjusted earnings per share of $0.34, both beating analyst estimates, the market focused on the company's concurrent announcement of its agreement to acquire Naveris. The precision oncology diagnostics company will be purchased for $160 million in upfront cash with potential milestone payments of up to $100 million.</p><p>Market participants appear to be weighing the substantial costs and integration risks associated with the acquisition against the strong quarterly fundamentals, leading to the sharp sell-off in the extended session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CDNA","symbol_name":"CareDx","start_time":0,"source_url":"","article_id":"1151658029","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151658029","pubTimestamp":1777438263,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"CareDx's stock experienced a significant decline of 8.58% in post-market trading on Wednesday, as investor sentiment turned negative following major corporate announcements.Despite reporting robust...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CDNA":"CareDx"},"translate_title":"个股追踪|CareDx盘后暴跌8.58%收购Naveris盖过强劲的Q1业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CDNA":1},"content_text":"CareDx's stock experienced a significant decline of 8.58% in post-market trading on Wednesday, as investor sentiment turned negative following major corporate announcements.Despite reporting robust first-quarter 2026 financial results that included a 39% year-over-year revenue increase to $118 million and adjusted earnings per share of $0.34, both beating analyst estimates, the market focused on the company's concurrent announcement of its agreement to acquire Naveris. The precision oncology diagnostics company will be purchased for $160 million in upfront cash with potential milestone payments of up to $100 million.Market participants appear to be weighing the substantial costs and integration risks associated with the acquisition against the strong quarterly fundamentals, leading to the sharp sell-off in the extended session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1151658029","isCrawlerRequest":true}